FlexDex Surgical Completes $5 Million Series B To Commercialize First Product Launch
BRIGHTON - FlexDex Surgical has completed a $5 million Series B financing round that will be used to commercialize the company’s first product, fund development of a second-generation device and a create a catalogue of instruments for laparoscopic surgery. Financing was led by current investors and included the co-founders, board members, individual investors and distributors.